Tianjin Ringpu Bio-Technology Co.,Ltd. Stock

Stocks

300119

CNE100000TV1

Pharmaceuticals

End-of-day quote Shenzhen S.E. 2026-07-17 5-day change 1st Jan Change
15.87 CNY -3.47% Intraday chart for Tianjin Ringpu Bio-Technology Co.,Ltd. +1.93% -15.45%

Valuation: Tianjin Ringpu Bio-Technology Co.,Ltd.

Market Cap 7.21B 1.06B 929M 857M 790M 1.49B 102B 1.52B 10.25B 4.03B 50.14B 3.99B 3.9B 173B P/E 2026 *
16.3x
P/E 2027 * 14x
Enterprise Value 7.73B 1.14B 996M 919M 847M 1.6B 110B 1.63B 10.99B 4.32B 53.76B 4.28B 4.19B 185B EV / Sales 2026 *
2.05x
EV / Sales 2027 * 1.77x
Free-Float
51.96%
Yield 2026 *
1.89%
Yield 2027 * 3.05%
06-09 Tianjin Ringpu Bio-Technology Co.,Ltd. signed an Equity Transfer Agreement to acquire an additional 30% stake in Tianjin Zhongrui Supply Chain Management Co., Ltd. from Ringpai National Chain Veterinary Hospital Management Co., Ltd. for CNY 65.9 million. CI
04-27 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-30 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-29 Tianjin Ringpu Bio-Technology Co.,Ltd. announces Annual dividend, payable on May 13, 2026 CI
03-26 Tianjin Ringpu Bio-Technology Co.,Ltd. announced that it expects to receive CNY 300 million in funding CI
11-27 Ringpu Bio-Technology Secures Registration For Feline Vaccine MT
25-10-29 Maxhealth Biotech Co. Ltd. announced that it has received CNY 400 million in funding from IDG Ventures, Shenzhen Capital Group Co., Ltd., Tianjin Ringpu Bio-Technology Co.,Ltd. CI
25-10-24 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
25-08-25 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
25-07-14 Ringpu Bio-Tech Forecasts Up to 70% Rise in H1 Profit MT
25-06-13 Jiangxi Twins Biotechnology Co., Ltd signed a letter of intent to acquire 67.18% stake in Hunan Sinoland Bio-Pharmacy Co., Ltd. from Tianjin Ringpu Bio-Technology Co.,Ltd. and Jingpeng Holding Group Co., Ltd for approximately CNY 115 million. CI
25-04-30 Tranche Update on Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback Plan announced on November 4, 2024. CI
25-04-29 Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback announced on November 4, 2024, has closed with 6,997,751 shares, representing 1.52% for CNY 129.98 million. CI
1 day-3.47%
1 week+1.93%
Current month+9.98%
1 month+3.73%
3 months-15.09%
6 months-21.24%
Current year-15.45%
1 week 15.52
Extreme 15.52
16.5
1 month 13.91
Extreme 13.91
16.5
Current year 13.91
Extreme 13.91
21.51
1 year 13.91
Extreme 13.91
24.03
3 years 11.25
Extreme 11.25
28.9
5 years 11.25
Extreme 11.25
28.9
10 years 6.3
Extreme 6.3
44.41
Manager TitleAgeSince
Chief Executive Officer 53 2023-03-29
Director of Finance/CFO 51 2022-04-27
Corporate Officer/Principal 45 2020-10-26
Director TitleAgeSince
Chairman 63 2008-05-11
Director/Board Member 37 2025-12-14
Director/Board Member 53 2019-12-24
Date Insider Type Main position Quantity % Market Cap.
6/16/26 Buy

Chief Executive Officer

500,000 0.1535%
5/24/23 Buy 3,000 0.0009%
5/23/23 Buy 1,000 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-3.47%+1.93%-27.37%-13.75% 1.1B
-0.46%+1.32%-48.97%-55.16% 32.24B
-0.46%+4.07%+72.66%+124.22% 12.96B
-3.77%+0.13%-20.34%-1.49% 3.74B
-0.15%+1.72%-8.17%+30.92% 3.13B
-3.66%-4.93%+21.51%+21.00% 1.94B
+3.69%+10.84%-21.88%+28.82% 1.79B
-3.51%+3.87%+12.04%+129.57% 1.4B
-0.15%+8.87%-19.24%-43.77% 1B
-1.79%+0.56%-10.86%-19.50% 967M
Average -1.37%+2.66%-5.06%+20.09% 6.03B
Weighted average by Cap. -0.77%+2.14%-12.93%+1.97%

Financials

2026 *2027 *
Net sales 3.77B 556M 486M 448M 413M 779M 53.53B 796M 5.36B 2.11B 26.22B 2.09B 2.04B 90.25B 4.26B 628M 549M 507M 467M 880M 60.51B 900M 6.06B 2.38B 29.64B 2.36B 2.31B 102B
Net income 441M 65.07M 56.86M 52.47M 48.37M 91.16M 6.27B 93.19M 627M 247M 3.07B 244M 239M 10.56B 527M 77.81M 68M 62.75M 57.84M 109M 7.49B 111M 750M 295M 3.67B 292M 286M 12.63B
Net Debt 519M 76.62M 66.96M 61.79M 56.95M 107M 7.38B 110M 739M 290M 3.61B 288M 281M 12.44B 337M 49.72M 43.45M 40.09M 36.95M 69.65M 4.79B 71.2M 479M 188M 2.34B 187M 183M 8.07B
Logo Tianjin Ringpu Bio-Technology Co.,Ltd.
Tianjin Ringpu Bio-Technology Co Ltd is a China-based company serving the animal health industry. The Company's main business areas are the research and development, production and sales of veterinary biological products, veterinary pharmaceutical preparations (chemicals, traditional Chinese veterinary medicines, disinfectants, and others), veterinary raw materials, veterinary functional additives, and provision of overall prevention and control of animal diseases. The Company's products include pharmaceuticals, vaccines, disinfectants, cleaning agents, and functional additives for pigs, chickens, waterfowl, cattle, sheep and pets, and others.
Employees
2,803
Date Price Change Volume
26-07-17 CN¥15.87 -3.47% 4,599,700
26-07-16 CN¥16.44 +0.92% 4,628,300
26-07-15 CN¥16.29 +1.62% 4,549,179
26-07-14 CN¥16.03 +1.52% 4,804,000
26-07-13 CN¥15.79 +1.41% 5,559,200
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
15.87CNY
Average target price
20.41CNY
Spread / Average Target
+28.61%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300119 Stock